Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges

MA Wu, A Taino, P Facchinetti, V Rossi… - Journal of Clinical …, 2024 - mdpi.com
Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a
complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data …

Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges.

MA Wu, A Taino, P Facchinetti, V Rossi… - Journal of Clinical …, 2024 - search.ebscohost.com
Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a
complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data …

Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges

MA Wu, A Taino, P Facchinetti… - Journal of clinical …, 2024 - pubmed.ncbi.nlm.nih.gov
Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a
complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data …

[HTML][HTML] Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges

MA Wu, A Taino, P Facchinetti, V Rossi… - Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a
complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data …

Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges

M Wu, A Taino, P Facchinetti, V Rossi… - Journal of Clinical …, 2024 - europepmc.org
Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a
complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data …

Venous Thromboembolism Management throughout the COVID-19 Era: Addressing Acute and Long-Term Challenges.

MA Wu, A Taino, P Facchinetti, V Rossi… - Journal of Clinical …, 2024 - europepmc.org
Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a
complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data …